<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Blanco-Alvarez VM</submitter><funding>Vicerrectoría de Investigación y Estudios de Posgrado</funding><pagination>375391</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4556331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2015</volume><pubmed_abstract>Prophylactic subacute administration of zinc decreases lipoperoxidation and cell death following a transient cerebral hypoxia-ischemia, thus suggesting neuroprotective and preconditioning effects. Chemokines and growth factors are also involved in the neuroprotective effect in hypoxia-ischemia. We explored whether zinc prevents the cerebral cortex-hippocampus injury through regulation of CCL2, CCR2, FGF2, and IGF-1 expression following a 10 min of common carotid artery occlusion (CCAO). Male rats were grouped as follows: (1) Zn96h, rats injected with ZnCl2 (one dose every 24 h during four days); (2) Zn96h + CCAO, rats treated with ZnCl2 before CCAO; (3) CCAO, rats with CCAO only; (4) Sham group, rats with mock CCAO; and (5) untreated rats. The cerebral cortex-hippocampus was dissected at d</pubmed_abstract><journal>Neural plasticity</journal><pubmed_title>Prophylactic Subacute Administration of Zinc Increases CCL2, CCR2, FGF2, and IGF-1 Expression and Prevents the Long-Term Memory Loss in a Rat Model of Cerebral Hypoxia-Ischemia.</pubmed_title><pmcid>PMC4556331</pmcid><funding_grant_id>NAT/2014</funding_grant_id><pubmed_authors>Tomas-Sanchez C</pubmed_authors><pubmed_authors>Martinez-Fong D</pubmed_authors><pubmed_authors>Hernandez-Castillo J</pubmed_authors><pubmed_authors>Brambila E</pubmed_authors><pubmed_authors>Torres-Soto M</pubmed_authors><pubmed_authors>Gonzalez-Barrios JA</pubmed_authors><pubmed_authors>Soto-Rodriguez G</pubmed_authors><pubmed_authors>Gonzalez-Vazquez A</pubmed_authors><pubmed_authors>Blanco-Alvarez VM</pubmed_authors><pubmed_authors>Eguibar JR</pubmed_authors><pubmed_authors>Limon ID</pubmed_authors><pubmed_authors>Leon-Chavez BA</pubmed_authors><pubmed_authors>Ugarte A</pubmed_authors><pubmed_authors>Aguilar-Peralta AK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prophylactic Subacute Administration of Zinc Increases CCL2, CCR2, FGF2, and IGF-1 Expression and Prevents the Long-Term Memory Loss in a Rat Model of Cerebral Hypoxia-Ischemia.</name><description>Prophylactic subacute administration of zinc decreases lipoperoxidation and cell death following a transient cerebral hypoxia-ischemia, thus suggesting neuroprotective and preconditioning effects. Chemokines and growth factors are also involved in the neuroprotective effect in hypoxia-ischemia. We explored whether zinc prevents the cerebral cortex-hippocampus injury through regulation of CCL2, CCR2, FGF2, and IGF-1 expression following a 10 min of common carotid artery occlusion (CCAO). Male rats were grouped as follows: (1) Zn96h, rats injected with ZnCl2 (one dose every 24 h during four days); (2) Zn96h + CCAO, rats treated with ZnCl2 before CCAO; (3) CCAO, rats with CCAO only; (4) Sham group, rats with mock CCAO; and (5) untreated rats. The cerebral cortex-hippocampus was dissected at d</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2025-05-18T12:46:01.929Z</modification><creation>2025-05-18T12:46:01.929Z</creation></dates><accession>S-EPMC4556331</accession><cross_references><pubmed>26355725</pubmed><doi>10.1155/2015/375391</doi></cross_references></HashMap>